SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
FRIEDMAN RICHARD H

(Last) (First) (Middle)
100 CLEARBROOK ROAD

(Street)
ELMSFORD NY 10523

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BioScrip, Inc. [ BIOS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
Officer (give title below) X Other (specify below)
Former Director
3. Date of Earliest Transaction (Month/Day/Year)
04/17/2012
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $.0001 Par Value 04/17/2012 S (3) 15,000 D $7.0101 (2) 384,579 D (1)
Common Stock, $.0001 Par Value 04/17/2012 M 14,900 A $6.36 399,479 D (1)
Common Stock, $.0001 Par Value 04/17/2012 (5) S 14,900 D $7.0095 384,579 D (1)
Common Stock, $.0001 Par Value 04/18/2012 S 2,400 D $7.0375 382,179 D (1)
Common Stock, $.0001 Par Value 04/18/2012 S 2,000 D $7.031 380,179 D (1)
Common Stock, $.0001 Par Value 04/18/2012 M 2,000 A $6.36 382,179 D (1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $6.36 04/17/2012 M 14,900 01/03/2006 (4) 05/31/2012 Common Stock, $.0001 Par Value 14,900 $0 121,886 D
Employee Stock Option (Right to Buy) $6.36 04/18/2012 M 2,000 01/03/2006 (4) 05/31/2012 Common Stock, $.0001 Par Value 0 $0 119,886 D
Employee Stock Option (Right to Buy) $7.03 01/02/2005 (4) 05/31/2012 Common Stock, $.0001 Par Value 200,000 200,000 D
Employee Stock Option (Right to Buy) $7.54 01/03/2007 (4) 05/31/2012 Common Stock, $.0001 Par Value 200,000 200,000 D
Employee Stock Option (Right to Buy) $7.7 01/02/2009 (6) 05/31/2012 Common Stock, $.0001 Par Value 130,000 130,000 D
Employee Stock Option (Right to Buy) $7.7 01/02/2009 (6) 05/31/2012 Common Stock, $.0001 Par Value 70,000 70,000 D
Option To Purchase Common Stock $6.52 04/29/2009 (6) 05/31/2012 Common Stock, $.0001 Par Value 112,500 112,500 D
Explanation of Responses:
1. Includes 10,000 shares owned jointly with Mr. Friedman's spouse.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.04, inclusive. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. These sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2011.
4. Fully Vested
5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.05, inclusive. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
6. Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.
/s/ Richard H. Friedman 04/23/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.